Newly diagnosed H3-mutated glioma

Clinical trials for Newly diagnosed H3-mutated glioma explained in plain language.

Never miss a new study

Get alerted when new Newly diagnosed H3-mutated glioma trials appear

Sign up with your email to follow new studies for Newly diagnosed H3-mutated glioma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Experimental vaccine takes on deadly childhood brain tumors

Disease control Ongoing

This phase 1 trial tests a peptide vaccine designed to target a specific mutation (H3K27M) found in certain aggressive brain tumors called diffuse midline gliomas. Fifteen newly diagnosed patients receive the vaccine along with the immunotherapy drug atezolizumab after standard r…

Matched conditions: NEWLY DIAGNOSED H3-MUTATED GLIOMA

Phase 1 • Sponsor: German Cancer Research Center • Aim: Disease control

Last updated Jun 27, 2026 07:51 UTC

Newly diagnosed H3-mutated glioma

Get alerted when new Newly diagnosed H3-mutated glioma trials appear

Experimental vaccine takes on deadly childhood brain tumors